HepatoChem Announces Issuance of U.S. Patent for its Industry Leading Photoreactors
February 22, 2021
Issuance of U.S. Patent No. 10,906,022 Protects HepatoChem’s Innovate Reaction Chamber Geometry That Maximizes Sample Irradiation
Beverly, Ma., February 22, 2021— HepatoChem, Inc., a leading manufacturer of photochemistry reactors, LEDs and accessories, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,906,022, which is directed to the assembly of a device that allows for conducting arrays of photochemical reaction conditions at room temperature with magnetic stirring.
U.S. Patent No. 10,906,022 covers the housing and assembly of a device that provides an opening for interchangeable vial holders, an adaptor for receiving light sources and ports for entry and exit of a fluid for adjusting the temperature of the reaction vials. Additional issued claims pertain to use of mirrors positioned within the reaction chamber to better disperse light and fully irradiate photochemical reaction samples. The ‘022 Patent contains 14 claims and expires in 2041.
This newly allowed patent is owned by HepatoChem, Inc., and is the first U.S. patent to issue in connection with the company’s photoreactor devices.
“MARC QUOTE,” said Marc Bazin, President and Founder of HepatoChem.
About HepatoChem, Inc.
HepatoChem, Inc. is a leading manufacturer for photochemistry reactors, LEDs and accessories. The company’s original photoreactor, the PhotoRedOx Box, has been cited in dozens of peer reviewed research papers regarding photochemistry and is valued for its ability to consistently reproduce reaction results and fully irradiate photochemical samples. The company has expanded its photoreactor portfolio to include the PhotoRedOx Duo offering double the capacity of its original design and the PhotoRedOx Box TC to enable photochemistry at temperatures between 0 and 80 degrees Celsius.
Director of Marketing